You are on Trendlyne United States. Click here to go to India website or make United States as your default

Treace Medical Concepts Inc XNAS: TMCI

Treace Medical Concepts Inc Live Share Price Today, Share Analysis and Chart

6.42 0.16 (2.56%)

43.63% Fall from 52W High

287.9K XNAS Volume

XNAS 23 Apr, 2025 4:01 PM (EDT)

Low Financial Strength
22.2 / 100
Expensive Valuation
15.5 / 100
Technically Neutral
45.3 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

Treace Medical Concepts Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26100150200250300Actual RevenueAvg. Estimate
Hit

Treace Medical Concepts Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-0.9
Avg. Estimate
-0.8
Low Estimate
-0.9
High Estimate
-0.8
Current EPS
Avg. Estimate

Consensus Recommendation

7 ANALYST Recommendations
BUY

Created with Highcharts 7.2.25Hold2Strong Buy

The consensus recommendation from 7 analysts for Treace Medical Concepts Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Treace Medical Concepts Inc Stock Analysis

Treace Medical Concepts Inc stock analysis with key metrics, changes, and trends.

Treace Medical Concepts Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$209.36 M11.89%positive

Annual Revenue rose 11.89%, in the last year to $209.36 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$55.74 M12.55%negative

Annual Net Profit fell 12.55% in the last year to $55.74 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio-7.18-negative

Price to Earning Ratio is -7.18, which is negative.

Stock Price$6.42-42.16%negative

Stock Price fell 42.16% and underperformed its sector by 50.16% in the past year.

Quarterly Revenue$68.71 M10.44%positive

Quarterly Revenue rose 10.44% YoY to $68.71 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$0.5 M92.02%positive

Quarterly Net profit rose 92.02% YoY to $0.5 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Debt to Equity Ratio0.62-positive

Debt to Equity Ratio of 0.62 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-44.45 %-44.45%negative

Return on Equity(ROE) for the last financial year was -44.45%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding28.81 %1.45%positive

Mutual Fund Holding increased by 1.45% in the last quarter to 28.81.

Interest Coverage Ratio-9.61-negative

Interest Coverage Ratio is -9.61, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

VIEW LESS


Loading data..

Treace Medical Concepts Inc - Company Profile

What does Treace Medical Concepts Inc do?

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Treace Medical Concepts Inc Management structure

All Gross Remunerations are in USD
Mr. John T. Treace
Chief Executive Officer and Director
6.6 M
2024
Gross Remuneration
Year
Mr. Scot Michael Elder
Corporate Secretary, Chief Legal and Compliance Officer
4.55 M
2024
Gross Remuneration
Year
Mr. Mark L. Hair
Chief Financial Officer and Principal Accounting Officer
4.49 M
2024
Gross Remuneration
Year

Treace Medical Concepts Inc Board of directors

All Gross Remunerations are in USD
Mr. Richard W. Mott
Lead Independent Director
225.73 K
2024
Gross Remuneration
Year
Mr. John K. Bakewell
Independent Director
224.78 K
2024
Gross Remuneration
Year
Mr. Lawrence W. Hamilton
Independent Director
224.78 K
2024
Gross Remuneration
Year
Ms. Deepti Jain
Independent Director
224.56 K
2024
Gross Remuneration
Year
Ms. Elizabeth S. Hanna
Independent Director
214.67 K
2024
Gross Remuneration
Year
Mr. Lance A. Berry, C.P.A.
Independent Director
205 K
2024
Gross Remuneration
Year

Treace Medical Concepts Inc FAQ

How is Treace Medical Concepts Inc today?
Treace Medical Concepts Inc today is trading in the green, and is up by 2.56% at 6.42.
Treace Medical Concepts Inc is currently trading up 2.56% on an intraday basis. In the past week the stock fell -3.02%. stock has been down -31.92% in the past quarter and fell -42.16% in the past year. You can view this in the overview section.